TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
ENTX

Entera Bio Ltd

Healthcare · Biotechnology

2.90$ +8.2% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Entera Bio Ltd (ENTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 16 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ENTX
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2.7 6.3 13 13 17 9.7 26 13 12 9.4 16
1.9 5.4 12 12 16 9.1 25 13 11 9.0 7.1
1.2 4.2 12 7.5 15 8.6 25 12 11 8.7 7.1
1.2 4.2 12 12 15 8.6 25 12 11 8.7 7.1
– – – 0.7 0.3 0.3 0.2 0.2 0.0 0.1 0.2
– – – 0.1 0.1 -0.1 – -0.3 – – –
0.2 0.2 0.2 0.2 0.5 0.5 0.4 0.2 – – –
0.7 0.7 0.7 0.7 0.6 0.6 – – – – –
28 32 45 3.2 4.8 2.2 3.4 1.4 1.4 1.3 2.9
0.8 11 2.0 1.8 4.6 1.8 3.2 1.3 1.1 1.2 2.2
21 9.9 37 – 0.2 0.2 0.2 0.1 0.1 0.2 0.2
0.4 0.1 0.6 0.5 0.3 0.2 0.2 0.0 0.1 0.1 0.4
21 4.8 3.9 – – – – – – – –
-26 -25 -32 10 12 7.5 23 12 10 8.1 13
-29 -31 -42 -52 -63 -70 -82 -95 -104 -114 -125
12 12 12 12 12 18 26 29 29 38 46

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?